Clinical trial
Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome
NCT00114127 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00114127 |
|---|---|
| Title | Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome |
| Official title | Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome |
| Lead sponsor | Massachusetts General Hospital, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anxiety Disorder |
| Intervention type | Drug |
| Interventions | Duloxetine, Placebo |
| Enrollment | 28 |
| Start date | Jun 1, 2004 |
| Primary completion | Nov 1, 2008 |
| Completion | Jul 1, 2010 |
| First posted | Jun 14, 2005 |
| Last update posted | Jun 10, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: